FG
TARO

Fiduciary Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Fiduciary Group’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,560
Closed -$223K – 186
2016
Q1 		$223K Sell
1,560
-50
-3% -$7.1K 0.06% 162
2015
Q4 		$249K Sell
1,610
-350
-18% -$51.1K 0.07% 154
2015
Q3 		$280K Sell
1,960
-134
-6% -$18.7K 0.09% 161
2015
Q2 		$301K Buy
+2,094
New +$299K 0.09% 162

Other funds holding TARO

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

Fiduciary Group's TARO Position: Q2 2016 in Review

Fiduciary Group sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 1,560 shares — an estimated $223K sold.

Fiduciary Group first reported a position in TARO in Q2 2015 and held it in 4 quarters. The position peaked at $301K in Q2 2015. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

  • Fiduciary Group reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
  • Fiduciary Group sold 1,560 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $223K.
  • Fiduciary Group first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2015 and held it in 4 quarters.
  • Fiduciary Group's Taro Pharmaceutical Industries Ltd. position peaked at $301K in Q2 2015.
  • 159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Fiduciary Group's 13F filing for Q2 2016, filed 10 Aug 2016.